Aria Life Sciences Private Limited
Trading of pharmaceutical and medical goods, including drugs, medicines, and cosmetics. Established in 2014 in Jaipur, Rajasthan.
2014 | Jaipur, Rajasthan (India) | Active
Aria Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -33.36%
- Profit Growth -72.07%
- Ebitda -66.08%
- Net Worth 116.33%
- Total Assets 30.00%
About Aria Life Sciences
Aria Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 October 2014 and has a history of Ten years and four months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Pranav Trivedi and Hetal Trivedi serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ2014PTC046349
- Company No.
046349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Pharma
Who are the key members and board of directors at Aria Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Trivedi  | Director | 07-Oct-2014 | Current |
| Hetal Trivedi | Director | 07-Oct-2014 | Current |
Financial Performance of Aria Life Sciences.
Aria Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 33.36% decrease. The company also saw a substantial fall in profitability, with a 72.07% decrease in profit. The company's net worth Soared by an impressive increase of 116.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aria Life Sciences?
In 2021, Aria Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aria Life Sciences?
Unlock and access historical data on people associated with Aria Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aria Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aria Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.